Has Albert Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,236 in general payments to Albert Lin, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Albert Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Albert Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Albert Lin, MD

Pain Medicine · Rancho Cordova, CANPI 1376935726

Payments from drug & device makers

$4,236in general payments, 2019–2025

Across 28 payments — averaging $151.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$3K
Nevro Corp.$350
SPR Therapeutics, Inc$185
Averitas Pharma Inc.$127
Acelrx Pharmaceuticals, Inc.$124
Boston Scientific$112
plus $129 from 2 others

What the payments were for

Grants$1,66739%
Travel & lodging$73917%
Food & beverage$1,83043%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	16	$3,208
Nevro Corp.	4	$350
SPR Therapeutics, Inc	2	$185
Averitas Pharma Inc.	1	$127
Acelrx Pharmaceuticals, Inc.	1	$124
Boston Scientific	2	$112
Stryker	1	$105
Pacira Pharmaceuticals Incorporated	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,236 in reported general payments places this provider in the 65th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$2,464

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	12	$1,068
Pregabalin	38	$620
Duloxetine Hcl	32	$437

Paid to pharmacies, not to this prescriber.

Other pain medicine in Rancho Cordova

Eric GrigsbyNapa$3.2M
Jason PopeSanta Rosa$2.8M
Javid GhandehariSanta Monica$2.7M
Alexander HerselThousand Oaks$2.1M
Krishnan ChakravarthyTemecula$1.9M
Kasra AmirdelfanWalnut Creek$1.7M
Ramana NaiduLarkspur$1.6M
Foead GeulaStudio City$1.3M
Xiang QianRedwood City$941K
Jacqueline WeisbeinNapa$863K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →